These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 19892046)

  • 1. Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
    Linefsky JP; Lin M; Pieper KS; Reist CJ; Berdan LG; Antman EM; Goodman SG; French JK; Guneri S; Roe MT; Newby LK; Harrington RA; Ferguson JJ; Califf RM; Mahaffey KW
    Am J Cardiol; 2009 Nov; 104(10):1330-5. PubMed ID: 19892046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
    Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
    J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
    Mahaffey KW; Roe MT; Kilaru R; French JK; Alexander JH; Berdan LG; Van De Werf F; Simoons ML; Weaver WD; White HD; Lincoff AM; Kleiman NS; Topol EJ; Harrington RA
    Am J Cardiol; 2005 Jun; 95(12):1404-8. PubMed ID: 15950560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromes.
    Novack V; Jotkowitz AB; Cutlip D; Amit G; Liebermann N; Porath A
    Postgrad Med J; 2008 Jan; 84(987):50-5. PubMed ID: 18230752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE).
    Goodman SG; Steg PG; Eagle KA; Fox KA; López-Sendón J; Montalescot G; Budaj A; Kennelly BM; Gore JM; Allegrone J; Granger CB; Gurfinkel EP;
    Am Heart J; 2006 Mar; 151(3):654-60. PubMed ID: 16504627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
    Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
    Galla JM; Mahaffey KW; Sapp SK; Alexander JH; Roe MT; Ohman EM; Granger CB; Armstrong PW; Harrington RA; White HD; Simoons ML; Newby LK; Califf RM; Topol EJ
    Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial.
    Miller CD; Banerjee A; Mahaffey KW; Kontos MC; Fermann G; Pollack CV; Antman E; Aylward P; Goodman SG; Santos R; Ferguson JJ; Califf RM; Hoekstra JW
    Eur Heart J; 2007 May; 28(9):1079-84. PubMed ID: 17405770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
    Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
    Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study.
    Menown IB; Mathew TP; Gracey HM; Nesbitt GS; Murray P; Young IS; Adgey AA;
    Am Heart J; 2003 Jun; 145(6):986-92. PubMed ID: 12796753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction.
    Aronow HD; Lincoff AM; Quinn MJ; McRae AT; Gurm HS; Houghtaling PL; Granger CB; Harrington RA; Van de Werf F; Topol EJ; Lauer MS;
    Am J Cardiol; 2008 Nov; 102(9):1119-24. PubMed ID: 18940276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
    Mahaffey KW; Roe MT; Kilaru R; Alexander JH; Van de Werf F; Califf RM; Simoons ML; Topol EJ; Harrington RA
    Eur Heart J; 2007 Feb; 28(4):425-32. PubMed ID: 17267458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
    Roe MT; Mahaffey KW; Kilaru R; Alexander JH; Akkerhuis KM; Simoons ML; Harrington RA; Tardiff BE; Granger CB; Ohman EM; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Topol EJ
    Eur Heart J; 2004 Feb; 25(4):313-21. PubMed ID: 14984920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.